FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and intended for treatment of hyperphenylalaninemia. Tetrahydrobiopterin or its pharmaceutically acceptable salt is applied, introduction being realised per orally within 0-30 minutes after meal.
EFFECT: method makes it possible to increase bioavailability of tetrahydrobiopterin in per oral intake.
13 cl, 31 tbl, 9 ex, 38 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAMTERENE OR NOLATREXED FOR USE IN TREATING PHENYLKETONURIA | 2020 |
|
RU2815197C2 |
| CRYSTALLINE FORMS OF (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN DIHYDROCHLORIDE | 2004 |
|
RU2434870C2 |
| SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BIOPTERIN DERIVATIVES, AND METHODS OF USING SUCH COMPOSITIONS | 2015 |
|
RU2694368C2 |
| APPLICATION OF PTERIDINE DERIVATIVES FOR TREATMENT OF HIGH INTRACRANIAL PRESSURE, SECONDARY ISCHEMIA AND DISEASES ASSOCIATED WITH HIGHER CONTENT OF CYTOTOXIC AND REACTIVE OXYGEN COMPOUNDS | 2003 |
|
RU2348410C2 |
| PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
| SOLID COMPOSITIONS BASED ON BETAHISTINE FOR ORAL ADMINISTRATION WITH NON-PULSATING PROLONGED RELEASE | 2018 |
|
RU2774644C2 |
| PHENYLALANINE-FREE PROTEIN FOR TREATMENT OF PKU | 2017 |
|
RU2764796C2 |
| β-L-2'-DEOXYNUCLEOSIDES USED IN HEPATITIS B TREATMENT | 1999 |
|
RU2300381C2 |
| COMPOSITIONS BASED ON FLAVONOIDS AND METHODS OF USING | 2016 |
|
RU2721425C2 |
| PREPARATION CONTAINING COMPLEX IRON (III) COMPOUNDS AND ACTIVE REDOX SUBSTANCE | 2006 |
|
RU2394597C2 |
